Skip Navigation


Europace Advance Access originally published online on November 8, 2007
Europace 2008 10(2):173-174; doi:10.1093/europace/eum247
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/2/173    most recent
eum247v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Puri, R.
Right arrow Articles by Young, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puri, R.
Right arrow Articles by Young, G. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org


ICDs

Complete extrusion of an implantable cardiac defibrillator

Rishi Puri*, Suchi Khurana and Glenn D. Young

Cardiovascular Investigation Unit, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia

* Corresponding author. Tel: +61 8 8222 4000; fax: +61 8 8222 5938. E-mail address: rishi_puri{at}hotmail.com

A 66-year-old man with type 2 diabetes mellitus, permanent atrial fibrillation on warfarin therapy, and severe ischaemic cardiomyopathy had an uncomplicated insertion of a single-lead implantable cardiac defibrillator (ICD) for primary prophylaxis of ventricular fibrillation. Device check 6 weeks after insertion revealed no evidence of wound dehiscence or local skin infection. Fourteen months later, the man presented to hospital with complete extrusion of his ICD below the original insertion point (Figure 1). He denied scratching the overlying skin, but did admit to feeling the generator move under the skin during the lifting of light furniture in the preceding month prior to complete extrusion. He presented afebrile, and his leucocyte count, ESR, and C-reactive protein were all within normal limits. Wound swabs grew skin flora only, and one out of three blood culture bottles grew coagulase negative Staphylococcus, thought to represent bacterial contamination. Transoesophageal echocardiography excluded lead vegetations. He was transferred to a nearby hospital and underwent successful device and lead extraction. This was performed under a general anaesthetic. The generator was disconnected and removed from the pocket, and the lead was dissected down to the left subclavian vein. After gentle traction failed to result in successful lead removal, the patient underwent successful lead extraction via the counter-traction method. He made an uneventful recovery.


Figure 1
View larger version (97K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Figure 1 Complete ICD generator extrusion below the original insertion point.

 
Skin erosion over permanent pacemaker (PPM) or ICD generators is a rare consequence of infection, with a reported incidence of 1% among late complications after PPM implantation. Total generator extrusion is also a rare consequence of skin erosion and is considered to be an even greater risk for potentially life-threatening bacterial contamination of the inner side of the generator pocket, with less than five reported cases in the literature, one of which involved an ICD generator extrusion 15 months after insertion. Risk factors contributing towards poor wound healing and subsequent skin erosion include poor hygiene, local irritation and infection, low socio-economic status, suppressed patient immunity, anticoagulation therapy, and type 2 diabetes mellitus. In the absence of sepsis or gross infection, some experts have proposed a lead-preserving strategy in the setting of early (<48 h) PPM/ICD exposure. However, the treatment of infected PPM/ICD generators remains a challenging clinical entity, with complete extraction of such devices carrying a 5% mortality rate. However, complication rates for device and lead extraction vary according to operator experience. With the worldwide exponential rise in device implantation rates, more and more clinicians will be faced with this challenging and life-threatening clinical scenario in the future. At present, there are no known clinical guidelines for the management of complete device extrusion, with a limited availability of clinicians suitably trained in device extraction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/2/173    most recent
eum247v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Puri, R.
Right arrow Articles by Young, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puri, R.
Right arrow Articles by Young, G. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?